引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 568次   下载 316 本文二维码信息
码上扫一扫!
通络止痛方治疗膝骨关节炎的效果及其对炎症因子影响
严菊芳,陈纯,袁丽
苏州市中西医结合医院骨伤科江苏苏州 215101
摘要:
目的 探讨通络止痛方治疗膝骨关节炎(KOA)的效果及对炎症因子影响。方法:选取本院2023年1月—2024年6月收治的KOA患者86例,应用随机数字表法分为对照组和研究组,每组各43例,对照组在常规西药治疗的基础上给予针刺治疗,研究组对照组的基础上给予通络止痛方治疗。两组均治疗4周。评估两组临床疗效、骨关节炎指数(WOMAC)及炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)]水平,采用Pearson分析WOMAC评分与炎症因子水平的相关性,统计并比较两组不良反应发生率。结果:两组临床疗效等级分布差异有统计学意义(P<0.05);研究组总有效率为93.02%,高于对照组的76.74%(P<0.05);与治疗前比较,两组治疗后WOMAC量表中疼痛、僵硬、日常生活难度评分及总分均降低(P<0.05),且研究组上述各维度评分更低,总分差值更高(P<0.05);两组治疗后TNF-α、IL-1β、IL-6均低于治疗前(P<0.05);与对照组比较,研究组治疗后TNF-α、IL-1β、IL-6更低(P<0.05);Pearson相关性分析显示,疼痛评分、僵硬评分、日常生活难度评分与TNF-α、IL-1β、IL-6均呈正相关(P<0.05);研究组、对照组不良反应发生率分别为13.95%、9.30%,二者比较差异无统计学意义(P>0.05)。结论:通络止痛方治疗KOA的效果显著,可明显缓解患者额的临床症状,降低炎症因子水平,安全性好。
关键词:  膝骨关节炎  通络止痛方  炎症因子
DOI:10.3969/j.issn.1007-6948.2025.02.008
投稿时间:2024-10-13
基金项目:2021年度苏州市科教兴卫青年科技项目(KJXW2021080)
Effect of Tongluo Zhitong prescription on knee osteoarthritis and its influence on inflammatory factors
YAN Ju-fang,CHEN Chun,YUAN Li
Department of Orthopedics, Suzhou Integrated Traditional Chinese and Western Medicine Hospital, Suzhou215101, China
Abstract:
Objective To explore the effect of Tongluo Zhitong prescription on knee osteoarthritis (KOA) and its influence on inflammatory factors. Methods The period from January 2023 to June 2024 is selected 86 patients with KOA were admitted divided into control group (n=43) and study group (n=43) by random number table method. The control group was given acupuncture treatment on the basis of conventional western medicine treatment, and the study group was given Tongluo Zhitong prescription on the basis of treatment. Both groups were treated for 4 weeks. The clinical efficacy and osteoarthritis index (WOMAC) of the two groups were evaluated, and the levels of inflammatory factors[tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β) and interleukin-6(IL-6)] in the two groups were compared. The correlation between WOMAC score and inflammatory factors was analyzed by Pearson, and the total incidence of adverse reactions was calculated. Results There was statistical significance in the distribution of clinical efficacy between the two groups(P<0.05). The total effective rate of the study group was 93.02%, which was higher than that of the control group 76.74%(P<0.05). Compared with before treatment, the scores of pain, stiffness, difficulty of daily living and total score of WOMAC scale in both groups were decreased after treatment (P<0.05), and the scores of the above dimensions in the study group were lower, the overall difference is higher(P<0.05). TNF-α, IL-1β and IL-6 after treatment were all lower than before treatment (P<0.05). Compared with the control group, the levels of TNF-α, IL-1β and IL-6 were lower in the study group after treatment (P<0.05). Pearson correlation analysis showed that pain score, stiffness score and difficulty of daily living score were positively correlated with TNF-α, IL-1β and IL-6 (P<0.05). The incidence of adverse reactions in study group and control group was 13.95% and 9.30%, respectively, and there was no significant difference between them(P>0.05). Conclusion Tongluo Zhitong prescription in the treatment of KOA is effective, can significantly alleviate clinical symptoms, reduce the level of inflammatory factors, good safety.
Key words:  Knee osteoarthritis  Tongluo Zhitong prescription  inflammatory factor

用微信扫一扫

用微信扫一扫